Categories

Category: WTF Health

Back Pain Treatment Under the Watchful Eye of Your SmartPhone Camera | Konstantine Mehl, Kaia Health

By JESSICA DaMASSA, WTF HEALTH

With a holistic mind-body approach to treating chronic back pain and COPD, Kaia Health is a digital therapeutics startup gaining a lot of attention from some really big players, including Optum Ventures (the venture arm of U.S. health insurance giant United Healthcare) which recently made an $8M follow-on investment to the startup’s Series A. What makes Kaia standout in a crowded field of digital health solutions focused on chronic pain? CEO Konstantin Mehl points to their proprietary tech, which uses a smartphone camera to provide real-time corrections to patients as they complete their physical exercises. As digital therapeutics like Kaia gain greater clinical validation and show widespread improvement to patients’ lives, Konstantin shares his hopes for the future of reimbursement for clinically-proven health tech.

Filmed at Frontiers Health Conference in Berlin, November 2019.

Advice for Health Tech: Focus on Results, Mission, & Critics | Molly Coye, AVIA

By JESSICA DaMASSA, WTF HEALTH

Molly Coye has spent more than two decades working to advance technology initiatives in healthcare, serving roles as diverse as the Commissioner of Health for the State of New Jersey, Chief Innovation Officer for UCLA Health, and now Executive in Residence for AVIA, which mentors more than 50 large health systems on tech selection, adoption, and implementation. With such rich experience working with healthcare incumbents, we asked Molly to size up the current class of innovators, technologists, developers, and investors bringing the latest health tech solutions to market. What have they gotten right? Where do they need to improve? “We’re not so good at cost of care and lack of access,” says Molly, who also sees potential for that to change thanks to the work of organizations like Health Tech for Medicaid and an increased focus on solutions that address the health needs of ALL patient populations.

Filmed at J.P. Morgan Healthcare Conference in San Francisco, January 2020.

Mainstream Adoption of Virtual Care is Like…Online Dating? | Stephany Verstraete, Teladoc Health

By JESSICA DaMASSA, WTF HEALTH

The shift in thinking required to go to a “virtual first” healthcare system may not be as unique to the health industry as we think. Teladoc Health’s new Chief Engagement Officer, Stephany Verstraete, got her start at Match.com — and explains the parallels she sees between the mainstream adoption of telehealth and what she experienced introducing online dating to the masses. Think about it: overcoming skepticism, addressing privacy concerns, and what Stephany says is most important, changing an ingrained behavior — are all challenges currently being faced by virtual care co’s. It’s not a bad idea to flirt with as we talk bigger trends in telehealth engagement.

Filmed at J.P. Morgan Healthcare Conference in San Francisco, January 2020.

Consulting for Health Tech Startup CEOs From the Guy Who Knows | Matthew Holt, SMACK Health

By JESSICA DaMASSA, WTF HEALTH

To hear Matthew Holt tear apart a pitch deck—or worse, a demo—one thinks of another Brit with a penchant for criticism and tell-it-like-it-is tough love. Could Matthew Holt be the Simon Cowell of health tech? Or maybe he’s got a point underneath all that gruff? Having co-founded Health 2.0, Matthew helped bring digital health and health tech startups into the mainstream by providing a friendly forum for entrepreneurs and established healthcare incumbents. Along the way, he’s suffered through his fair share of demos and pitches, and watched all corners of the healthcare market as it reacted to (and invested in) tech health solutions. Now bringing that 30 years of wisdom to startups seeking coaching, help with strategy, business model design, fundraising, and, of course, demoing and pitching, Matthew explains how he hopes to help the current class of up-and-coming health startups via his consulting biz, SMACK Health.

Filmed at HLTH 2019 in Las Vegas, October 2019.

Consumer Health Tech Market Outlook for 2020 | Robert Garber, 7Wire Ventures

By JESSICA DaMASSA, WTF HEALTH

7Wire Ventures is a venture fund that invests in early-stage healthcare companies that are focused on connecting with the healthcare consumer — kind of like one of the most successful companies in its portfolio, Livongo, which went public in 2019. Robert Garber, a partner with the firm, stops by to share his point-of-view on where the consumer health tech market will be headed in 2020, if we’ll see more exits, and whether or not consumer health will be able to gain traction with healthcare’s established players like payers and health systems.

Filmed at J.P. Morgan Healthcare Conference in San Francisco, January 2020

Behind the Big Deal: Teladoc Health’s Acquisition of InTouch Health | Joe DeVivo, InTouch Health

By JESSICA DaMASSA, WTF HEALTH

It was a seminal moment in virtual care as Teladoc Health acquired Intouch Health for $600 million, effectively taking its mostly direct-to-consumer telehealth platform directly into more than 2,500 care providers — or, as they say, “from hospital to home.” We caught up with InTouch Health’s CEO, Joe DeVivo, to hear his thoughts on the deal, including what it means for the further advancement of virtual care and for the digital health industry at-large.

Filmed at J.P. Morgan Healthcare Conference in San Francisco, January 2020

What’s Ahead for Livongo & the Health Tech Market in 2020? | Glen Tullman, Livongo

By JESSICA DaMASSA, WTF HEALTH

What does Glen Tullman, Chairman of Livongo, expect from the health tech market in 2020? Livongo may have started a “race for the exits” in digital health with its 2019 IPO, and Glen says he “wants a healthy, consumer-facing digital health market” to help his own business thrive. Does that mean he anticipates more IPOs from the health tech sector this year? We get Glen’s predictions after we catch up on Livongo’s recent moves to partner with DexCom and test a new pathway to reimbursement via Express Scripts’ Digital Health Formulary.

Filmed at J.P. Morgan Healthcare Conference in San Francisco, January 2020.

Scaling Up One Drop: From Walmart & Apple Stores to Employers & Bayer | Jeff Dachis, One Drop

By JESSICA DaMASSA, WTF HEALTH

On the heels of a $40M Series B funding round led by Bayer, One Drop CEO Jeff Dachis stops by to hit the highlights about how the digital health platform is touching the lives of 1.6 million users in nearly 200 countries. Focused on chronic conditions like diabetes, pre-diabetes, hypertension, etc. One Drop is unique in the BIG direct-to-consumer business they’ve built through partnerships with Walmart and Apple stores. While Jeff says their growth capital will go toward expanding their heath plan and employer business, there’s also room for growth with Bayer, which could help expand the company’s core operating platform into other therapeutic areas like cardiovascular disease, oncology, and women’s health.

Filmed at Frontiers Health in Berlin, Germany, November 2019.

From Ophthalmology Clinic to At-Home Device: Disrupting OTC Testing | Helge Sudkamp, Visotec

By JESSICA DaMASSA, WTF HEALTH

Optical coherence tomography, otherwise known as OCT testing, gives eye doctors a glimpse of the retina to help detect eye diseases like glaucoma, macular degeneration, retinopathy, and more. So, what’s wrong with current methods of testing? Helge Sudkamp, CEO & co-founder of Visotec, explains how traditional OCT machines are huge, bulky and expensive — limiting scanning to infrequent visits at the doctor’s office. His company has a new take on OCT tech that puts the scanning into patients’ hands with a small, portable device that can be used daily AT HOME. What can daily at-home monitoring offer eye patients and their doctors? Never-before-collected data on the day-to-day progress of eye disease for one. Find out more about how Visotec ultimately hopes to leverage this new info to build algorithms into their devices that will be able to detect biomarkers that help identify eye diseases faster.

Filmed at Bayer G4A Signing Day in Berlin, Germany, October 2019.

Taking Healthcare Innovation Beyond the “Peloton Crowd” | Andy Slavitt, Town Hall Ventures

By JESSICA DaMASSA, WTF HEALTH

Andy Slavitt, former Acting Administrator of the Centers for Medicare and Medicaid Services and founder and partner at Town Hall Ventures, talks about how venture capitalists and health tech startups can help make healthcare more affordable and accessible for the 130 million Americans beyond the “Peloton crowd.” We ask Andy if he thinks “social determinants of health” is more than just an industry buzzword, get his advice for startups motivated to make a difference, and hear his predictions for what will change healthcare in this new decade.

Filmed at J.P. Morgan Healthcare Conference in San Francisco, January 2020.

Registration

Forgotten Password?